The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

US biotech major Biogen and Chicago, Canada-based Vanqua Bio today announced a license agreement granting Biogen exclusive ...

French pharma major Sanofi (Euronext: SAN) reported third-quarter 2025 revenue of 12.4 billion euros ($13.2 billion), up 7% ...

US clinical-stage biotech Tango Therapeutics has announced the pricing of an underwritten offering of 21,023,337 shares of ...

Japan’s Mitsubishi Tanabe Pharma (MTPC) yesterday announced that the US Food and Drug Administration (FDA) has issued a ...

French biotech Abolis Biotechnologies has signed a strategic partnership with EUROAPI (EPA: EAPI) to develop microbial ...

The Association for Accessible Medicines (AAM) has filed for a federal injunction to prevent Connecticut from enforcing a new ...

A Swiss biotech company that applies quantum-informed science, causal biology, multi-omics and proprietary AI to early-stage ...

Elixion Biotech has emerged from stealth with a breakthrough that it claims could reshape early-stage drug discovery.

Research from GlobalData highlights the strength of Novartis' (NOVN: VX) position in IgA nephropathy (IgAN), following strong ...

The USA’s Institute for Clinical and Economic Review (ICER) today released its new “Launch Price and Access Report,” finding ...